Main > A1. CORP. INDEX. Hn-Hz > Hyloris Pharmaceuticals SA./P C2

---

Hyloris Pharmaceuticals SA./P C2's subsections
2021. 10.08. Heart Failure
2021. 10.13. Acute Coronary Syndrom
2023. 10.18. U.S. FDA Approval
web-site

Hyloris Pharmaceuticals SA./P C2's products
This section has no products